Evidence map›Paper›PMID 42891703›Full record

ArticleAbdominal radiology (New York)2026

Radiological lymphoceles and clinically relevant lymphatic complications after retroperitoneal lymph node dissection for testicular cancer: a longitudinal imaging study.

Sebastian Lenart, Hamed Wafa, Ute Pichler, Friedrich Aigner, Leonhard Gruber, Alexander Hoeller, Gerald Klinglmair, Reinhard Peschel, Clemens Mikulits, Irene Resch and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Abdominal radiology (New York), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Sebastian LenartDepartment of Urology, Hospital of the Brothers of St. John of God, Vienna, Austria. sebastian.lenart@gmx.at.ORCID https://orcid.org/0000-0002-7609-1207
Hamed WafaDepartment of Urology, Comprehensive Cancer Centre Innsbruck, Innsbruck Medical University, Innsbruck, Austria.
Ute PichlerDivision of Nutrition and Dietetics, University Hospital Innsbruck, Innsbruck, Austria.
Friedrich AignerDepartment of Radiology, Innsbruck Medical University, Innsbruck, Austria.
Leonhard GruberDepartment of Radiology, Innsbruck Medical University, Innsbruck, Austria.
Alexander HoellerDivision of Nutrition and Dietetics, University Hospital Innsbruck, Innsbruck, Austria.
Gerald KlinglmairDepartment of Urology, Comprehensive Cancer Centre Innsbruck, Innsbruck Medical University, Innsbruck, Austria.
Reinhard PeschelDepartment of Urology, Comprehensive Cancer Centre Innsbruck, Innsbruck Medical University, Innsbruck, Austria.
Clemens MikulitsDepartment of Urology, Hospital of the Brothers of St. John of God, Vienna, Austria.
Irene ReschDepartment of Urology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
Renate PichlerDepartment of Urology, Comprehensive Cancer Centre Innsbruck, Innsbruck Medical University, Innsbruck, Austria.ORCID https://orcid.org/0000-0001-5286-9048

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePostoperative lymphoceles are recognized complications of retroperitoneal lymph node dissection (RPLND) for testicular germ cell tumours (TGCT). Previous studies have predominantly reported symptomatic or intervention-requiring lymphoceles, whereas the incidence, temporal evolution, and clinical relevance of lymphoceles on postoperative imaging remain poorly defined. We evaluated radiologically detected lymphoceles and clinically relevant lymphatic complications after post-chemotherapy RPLND (PC-RPLND) using routine serial imaging.

methodsThis retrospective single-centre cohort study included 86 consecutive patients who underwent PC-RPLND under a standardized perioperative management protocol. Postoperative imaging consisted of ultrasound at postoperative day 5-7 and 3-4 weeks, followed by computed tomography at 3 and 12 months. The primary endpoint was the incidence of any imaging-detected lymphocele during follow-up. Secondary endpoints included lymphocele prevalence at each imaging time point, clinically relevant lymphatic complications, postoperative complications, and exploratory factors associated with lymphocele formation.

resultsOf 86 included patients, 85 were evaluable for the primary endpoint. Overall, 46 patients (54.1%) had at least one imaging-detected lymphocele during follow-up. Lymphoceles were most frequently detected at discharge (36/84, 42.9%) and decreased over time to 32.8% (19/58) at 3-4 weeks, 31.5% (17/54) at 3 months, and 15.8% (9/57) at 12 months. Clinical follow-up was available for 65 patients. Clinically relevant lymphatic complications occurred in only 3 patients (4.6%), comprising two cases of lymphatic/chylous ascites and one lymphatic fistula associated with a small precaval lymphocele. Among 49 patients with paired 3- and 12-month CT, 10 of 16 lymphoceles present at 3 months had resolved by 12 months, whereas only one was newly detected (exact McNemar p = .012). Exploratory analyses identified no significant associations between imaging-detected lymphocele formation and patient characteristics, tumour-related factors, surgical approach, or extent of lymphadenectomy.

conclusionsLymphoceles are frequently detected by routine serial imaging after PC-RPLND but rarely translate into clinically relevant lymphatic morbidity. Radiologically detected lymphoceles should therefore be distinguished from clinically relevant lymphatic complications when interpreting surveillance imaging, counselling patients, and reporting postoperative outcomes after RPLND.

Indexed as

LymphadenectomyLymphocelesTesticular cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.